Every pharmacy that accepts insurance is operating under a stack of third-party payer contracts — agreements with pharmacy benefit managers (PBMs), health plans, and sometimes direct employer or government payers. These contracts govern reimbursement, network participation, audit rights, and a long list of operational obligations. This post is a general, informational overview of how these contracts tend to be structured. It is not contract-negotiation advice, and nothing here should be read as a recommendation for how to handle a specific contract — that’s a conversation for qualified legal or business counsel who can review your actual agreement.
What a third-party payer contract typically covers
Most PBM or payer contracts, regardless of the specific payer, address a similar set of categories:
Reimbursement terms — how the pharmacy is paid for each claim, typically referencing a pricing benchmark (like AWP, WAC, or NADAC) minus a discount, plus a dispensing fee. Some contracts use maximum allowable cost (MAC) lists for generic drugs, which can be updated by the payer without renegotiating the underlying contract.
Network participation terms — the conditions under which a pharmacy is included in (or excluded from) a payer’s pharmacy network, including credentialing requirements and performance standards.
Audit rights — most contracts give the payer or its PBM broad rights to audit claims after the fact, including desk audits (documentation review) and on-site audits. This is a major area of pharmacy compliance exposure, separate from the contract terms themselves.
Termination provisions — the conditions and notice periods under which either party can end the relationship, and what happens to in-process claims when that happens.
Fee structures beyond reimbursement — some contracts include network access fees, DIR (direct and indirect remuneration) fees, or performance-based fee adjustments tied to metrics like generic dispensing rate or patient adherence measures.
Why these contracts get complicated fast
Two things make third-party payer contracts particularly hard to manage. First, reimbursement isn’t always final at the point of sale — DIR fees and performance-based adjustments can claw back revenue weeks or months after a claim is paid, based on metrics the pharmacy may not see in real time. Second, MAC list pricing for generics can change frequently, sometimes without the same notice period that governs the rest of the contract, which is a recurring source of dispute between pharmacies and PBMs.
State legislation has increasingly targeted specific PBM practices — MAC list transparency and appeal rights, DIR fee timing, and network adequacy requirements are all areas where state law can affect what’s enforceable in a contract regardless of what the contract itself says. See our overview of PBM state regulations for how this varies by state, and our guide to PBM audit preparation for the operational side of responding to an audit once one starts.
Why this is a legal and business decision, not a pharmacy-practice one
Evaluating and negotiating a specific third-party payer contract involves financial modeling, legal risk assessment, and sometimes leverage considerations that go well beyond what general information can responsibly address. Contract terms interact with state PBM regulation, federal law in some cases, and the pharmacy’s own business structure. A term that’s standard and acceptable for one pharmacy’s volume and payer mix may be a bad deal for another.
If you’re evaluating a new contract, renewing an existing one, or responding to a contract dispute, that’s a job for a qualified healthcare attorney or contract specialist familiar with pharmacy reimbursement — not something to work through generically. Pharmacy ownership structure can also affect contracting leverage and obligations; our post on pharmacy ownership licensing requirements touches on some of the related compliance considerations.
Bottom line
This overview describes general concepts in pharmacy third-party payer contracting — it is not legal or business advice and shouldn’t be used as a basis for negotiating or signing a specific contract. Contract terms, state PBM regulations, and reimbursement structures vary widely and change frequently; confirm current requirements and evaluate specific agreements with qualified legal and business counsel.
For tracking the regulatory side of pharmacy compliance across states — separate from contract negotiation — start a free 14-day trial of RxByState →